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Introduction {#sec1}
============

A prerequisite of the signal sequence hypothesis is the availability of a membrane-bound machinery for recognition and transport of preproteins ([@bib2]). Protein secretion in bacteria generally relies on the peripheral association of the ATPase SecA with the protein-channel complex SecYEG ([@bib6]). Both factors interact with the preprotein signal sequence ([@bib16; @bib24; @bib31]), which is transferred from SecA to SecYEG prior to protein translocation across the membrane through the center of SecY ([@bib7; @bib31]). Membrane proteins require the signal recognition particle (SRP) and its receptor for nascent chain targeting to the Sec complex prior to translocation, which is driven by their synthesis. A lateral gate for insertion is formed between transmembrane segment (TMS) 2b and TMS 7 of SecY, which is also the binding site for the signal sequence ([@bib24; @bib31]).

The structure of the protein-channel complex has been resolved by electron and X-ray crystallography. The former was determined in the membrane and revealed SecYEG dimers in a back-to-back configuration ([@bib5]). This dimeric arrangement is required for translocation ([@bib9]), even though translocation proceeds through a single SecYEG complex ([@bib22]). Together, the two copies provide a productive high-affinity binding site for SecA, to secure the interaction during transport. Notably, the ADP-associated state of SecA has a lower affinity for SecYEG, compared to the ATP-bound state ([@bib25; @bib27]). Therefore, the 10-fold higher affinity of SecA for the dimer over the monomer ([@bib9]) helps prevent the dissociation and abolition of translocation at the ADP-associated stage.

The X-ray structure, determined using solubilizing detergent, identified monomers with the central channel held closed by an annulus of hydrophobic residues at the center of SecY and a short helix (2a) or plug ([@bib23; @bib31]). The structure of the SecYEG-SecA complex (also in detergent solution) contains one copy of each and shows that the association opens a "window" at the lateral gate by the separation of TMS 2b and 7, in preparation for signal sequence binding and protein translocation ([@bib32]). The plug and the TMS lining the channel and lateral gate need to move further in order to accommodate and transport secretory and membrane proteins. The nature of this conformational change holds the key to understanding the molecular mechanism of transport.

Recently, the *Escherichia coli* SecYEG complex has been visualized in the membrane environment associated with a ribosome nascent chain complex (RNC) ([@bib15]). The nascent chain contains the N-terminal signal anchor (SA) of FtsQ, a classical substrate of the cotranslational insertion pathway. In this structure, the SecY conformation is apparently very similar to the posttranslational complex of SecYEG-SecA determined without any substrate ([@bib32]). A density on the outside of the complex at the lateral gate was attributed to the SA.

In order to learn more about the active process we set out to determine the structure of SecYEG, using electron microscopy of two-dimensional (2D) crystals, in association with a substrate polypeptide. Our approach involved the analysis of membrane-bound SecYEG in complex with a 40 amino acid (aa) polypeptide of the N terminus of the precursor of LamB. This protein is a β-barrel outer membrane porin and a typical substrate of the SecA-dependent posttranslational secretory pathway. A number of mutations and deletions of the signal sequence, mostly around the central hydrophobic core, render the substrate defective in translocation ([@bib12]). Suppressors of these mutations, the *prl* alleles, have been instrumental in the identification and analysis of SecY (*prlA*), SecE, SecG, and SecA ([@bib13; @bib29]).

The interaction of the signal sequence with SecA and SecYEG is retained by representative synthetic peptides of LamB (denoted SS). The association with SecA results in the competitive inhibition of protein translocation; the structural basis of the recognition was characterized by NMR spectroscopy ([@bib16]). The peptide also opens channels in membranes containing SecYEG ([@bib28]). In addition, signal sequence peptides, including of LamB, act as allosteric activators of the translocation machinery, allowing the efficient transport of secretory proteins without signal sequences ([@bib18]).

We further explored the ability of the peptide to bind and activate the SecYEG complex. A peptide containing the signal sequence and a short stretch of the mature protein was useful in this respect and allowed us to stabilize and crystallize its complex with SecYEG for structure determination by electron cryomicroscopy. The map of the membrane-bound translocon engaged and activated by this preprotein mimic provides a clear view of the signal sequence and the TMS of the SecYEG dimer. The conformational changes induced by the association help to explain some of the *prlA* phenotypes, and suggest a mechanism for the initiation of preprotein transport and channel opening.

Results {#sec2}
=======

A Peptide Mimic of the Preprotein Acts on the Physiological Translocation Site {#sec2.1}
------------------------------------------------------------------------------

An extended 40 aa peptide of the LamB signal sequence (SS) containing an additional 15 aa β strand of the mature protein (SS-β~1~) quantitatively inhibits assays reconstituting SecA/ATP-driven translocation of the preprotein proOmpA into proteoliposomes containing SecYEG ([Figures 1](#fig1){ref-type="fig"}A and 1B). Conversely, a similar peptide with a 4 aa deletion (SS~Δ4~-β~1~), corresponding to a classic defective signal sequence ([@bib12]), did not.

The SS-β~1~ Peptide Transactivates SecYEG Conferring the Ability to Translocate a Signal Sequence-less Secretory Protein {#sec2.2}
------------------------------------------------------------------------------------------------------------------------

To confirm the peptide was acting physiologically on SecY, we exploited the allosteric transactivation of translocation by signal sequence peptides ([@bib18]). SS-β~1~ and SS~Δ4~-β~1~ were titrated into translocation reactions of OmpA without signal sequence ([Figure 1](#fig1){ref-type="fig"}C). As expected, the wild-type peptide conferred the ability to promote translocation of OmpA much more effectively than the mutant.

Next, the SecYEG complex was reconstituted into phospholipid vesicles in the absence or presence of SS, SS-β~1~, or SS~Δ4~-β~1~. The vesicles were then reisolated from the excess unbound peptide and analyzed for incorporated peptide and their ability to promote the translocation of OmpA. SS and SS-β~1~, but not SS~Δ4~-β~1~, were retained following coreconstitution with SecYEG ([Figure 1](#fig1){ref-type="fig"}D), and permitted the translocation of OmpA ([Figure 1](#fig1){ref-type="fig"}E). The induced increase in OmpA transport was not as high as observed upon direct addition to translocation assays ([Figure 1](#fig1){ref-type="fig"}C). This was due to the inevitable dissociation of some of the SecYEG-bound peptide during vesicle reisolation from the unbound excess peptide (the apparent K~d~ ∼10 μM; [Figure 1](#fig1){ref-type="fig"}A). Therefore, the resulting partially loaded Sec complex, as expected, exhibited a lower level of activation. Nevertheless, the results do show the preprotein mimic must be acting directly on the SecYEG complex. In this membrane- and substrate-bound state the complex is unlocked and primed to allow the passage of the mature part of the secretory protein.

Growth and Analysis of 2D Crystals of SecYEG with and without SS-β~1~ {#sec2.3}
---------------------------------------------------------------------

Electron microscopy of 2D crystals enables visualization of membrane proteins reconstituted into lipid bilayers. The structure of SecYEG without bound peptide previously determined in this way revealed the complex was a dimer in the membrane ([@bib5]), whereas all structures of SecY complexes determined in the presence of detergent showed monomers ([@bib11; @bib31; @bib32]). As this particular dimeric arrangement of SecYEG is obligatory for the productive engagement of substrate ([@bib9]), we used 2D crystallography again for the complex with preprotein peptide. The membrane-embedded crystals were prepared in much the same way as the vesicles for activity measurements.

Crystals were grown with or without SS-β~1~ and then isolated from the crystallization liquor and analyzed by SDS-PAGE. Those grown in the presence of the peptide retained it ([Figure 1](#fig1){ref-type="fig"}F). Its resistance to proteolysis suggested that the peptide was occluded within the crystalline membranes, rather than at the surface. For the purposes of data collection the sample was taken directly from the crystallization liquor, where the peptide was maintained in solution at all times to prevent the dissociation observed above.

The Architecture of the SecYEG Complex Bound to the Preprotein Peptide {#sec2.4}
----------------------------------------------------------------------

The unit cell dimensions (112 × 58 Å) of the 2D crystals with or without the peptide were the same, and similar to those obtained previously (104 × 57 Å) ([@bib5]). Images of SecYEG-SS-β~1~ crystals recorded at various tilt angles were used for 3D reconstruction ([Table S1](#mmc1){ref-type="supplementary-material"} available online). As before, the 3D map showed that the crystals consisted of two stacked membranes connected by facing cytosolic loops of SecY ([Figure S1](#figs1){ref-type="fig"}). The two layers were more tightly packed than in the former study ([@bib5]), reducing the thickness of the crystals. This slight difference in the crystal packing was independent of the peptide and most likely the result of subtle variations in the growth conditions.

Previously, the structure of SecYEG alone was of sufficient quality to fit all 15 TMS of SecY (10), SecE (3), and SecG (2) ([@bib5]). This fitting was subsequently verified by the X-ray structure ([@bib4; @bib31]). The new map was of very similar resolution and quality ([Figures 2](#fig2){ref-type="fig"}A and 2B; [Table S1](#mmc1){ref-type="supplementary-material"}). Clear rod-like densities of transmembrane helices enabled accurate docking of an atomic homology model of *E. coli* SecYEG ([@bib4; @bib9]; [Figures 2](#fig2){ref-type="fig"}A and 2C--2E). All TMS could be accurately fitted, except the highly tilted TMS 3 of SecE, due to the inherently lower resolution perpendicular to the membrane plane ([Table S1](#mmc1){ref-type="supplementary-material"}; [@bib5]).

The Asymmetric Association of the Preprotein Peptide to the SecYEG Dimer {#sec2.5}
------------------------------------------------------------------------

The overall architecture of the complex associated with the peptide was largely unchanged from that without it ([@bib5]), showing the SecYEG dimers in the functional back-to-back conformation ([@bib9]; [Figures 2](#fig2){ref-type="fig"}A and 2B). However, upon closer inspection the maps revealed significant differences. In the absence of substrate the two SecYEG complexes had the same structure, apart from random noise (correlation coefficient \[CC\] = 0.557) ([Figure 2](#fig2){ref-type="fig"}B). Previously, the noise contribution was reduced by applying noncrystallographic 2-fold symmetry ([@bib5]). In the presence of peptide, however, the structure of one SecYEG complex appeared to be different from its partner (CC = 0.467), and from the two copies of the complex determined without peptide prior to symmetry imposition ([Figure 2](#fig2){ref-type="fig"}B; CC = 0.417 and 0.406). This is consistent with substrate binding and induced conformational change in only one of the SecYEG complexes.

The TMS of the *E. coli* homology model were fitted individually to each monomer complex of the equivalent unsymmetrized maps determined with and without the preprotein peptide. One of the monomer complexes of the peptide-bound dimer possesses an extra prominent density just outside the lateral gate, adjacent to TMS 2b, 7, and 8 ([Figures 2](#fig2){ref-type="fig"}A and 2B, red circle). This was the only significant density within the membrane not accounted for by the SecYEG model ([Figures 2](#fig2){ref-type="fig"}D and 2E), and was therefore assigned to the bound substrate. The extra feature was clearly absent from the other monomer complex in the peptide-bound SecYEG dimer, as well as from both complexes of the dimer determined without bound preprotein ([@bib5]; Figures [2](#fig2){ref-type="fig"}A, 2B, and [3](#fig3){ref-type="fig"}). Further additional densities unaccounted for by adjacent SecYEG dimers ([Figure 2](#fig2){ref-type="fig"}A) are due to the cytosolic loops of complexes in the other membrane layer ([Figure S1](#figs1){ref-type="fig"}), which do not penetrate the membrane (e.g., asterisk in [Figure 2](#fig2){ref-type="fig"}D).

Signal-Sequence-Induced Conformational Changes in SecYEG {#sec2.6}
--------------------------------------------------------

The structure of the hydrophobic α-helical core of the LamB signal sequence determined in complex with SecA ([@bib16]) fits into the extra density outside the lateral gate (Figures [2](#fig2){ref-type="fig"}A and [3](#fig3){ref-type="fig"}A). The mutations resulting in defective signal sequences, including the SS~Δ4~ deletion used above, all fall within this helical core ([@bib12]; cyan in [Figures 4](#fig4){ref-type="fig"}A and 4B). The signal sequence location in the map does not agree exactly with the proposed position intercalated between TMS 2b and 7 ([@bib31]), but is consistent with defined crosslinks between the signal sequence and phospholipids, TMS 2b, 7, and 8 ([@bib24]). The hydrophobic core of the helix also correlates well with its central position in the lipid bilayer.

The signal sequence helix is in close contact with TMS 2b, which has consequently tilted away from the lateral gate (compare [Figure 3](#fig3){ref-type="fig"}A with [Figures 3](#fig3){ref-type="fig"}C and 3D; [Figures 4](#fig4){ref-type="fig"}A and 4B). Another change triggered upon contact with the preprotein peptide is a major relocation of TMS 7: a straightening of 40° toward center of the channel brings its periplasmic end 15 Å toward TMS 5 and 10 ([Figure 4](#fig4){ref-type="fig"}B). This, in turn, results in the displacement of the channel plug (helix 2a) 10 Å toward TMS 3 of SecE ([Figures 4](#fig4){ref-type="fig"}A and 4B). Our confidence in the positioning of the signal sequence and the description of the conformational change is reflected by the fits to well-resolved and clear densities (Figures [2](#fig2){ref-type="fig"}C--2E and [3](#fig3){ref-type="fig"}A; see helices denoted 2a, 2b, 7, and SS).

The local differences in TMS 2b and 7 between the two monomeric complexes in the substrate-bound dimer are more pronounced than those between the peptide-containing monomer in this dimer and the complex crystallized without peptide (compare [Figure 3](#fig3){ref-type="fig"}A with [Figure 3](#fig3){ref-type="fig"}B, and [Figure 3](#fig3){ref-type="fig"}A with [Figures 3](#fig3){ref-type="fig"}C and 3D). The lateral gate in the unoccupied complex of the substrate-bound dimer appears to be more tightly closed than in both copies of the inactive complex.

Discussion {#sec3}
==========

The Sec complex, like most membrane proteins, is prone to detergent exposure and the depletion of lipids ([@bib1; @bib9; @bib17]). In this study, these known destabilizing effects on the active arrangement of the translocon have been avoided by crystallizing the complex within the membrane. Its reconstitution with a bona fide preprotein mimetic at the physiological site has provided a detailed view of an activated translocon, showing just one substrate bound per SecYEG dimer.

This substrate-induced asymmetry is consistent with the requirement for two distinct copies of the channel, with only one of them being active ([@bib9; @bib22]) and evidently, is inherent to SecYEG. The binding of substrate to one SecYEG appears to induce an inaccessible state in the other, possibly accounting for the preference of the dimer to bind only one copy of the preprotein.

In the active monomer the substrate binding site and induced conformational changes in the SecYEG protein channel are consistent with the critical role played by TMS 2b, 7, and the plug in substrate recognition and transport ([@bib31]). The genetic analyses of LamB secretion also support this interpretation ([@bib12; @bib13]). The *prl* suppressors of defective signal sequences do not directly complement substrate binding. Instead they are thought to stabilize the open form of the complex (or destabilize the closed form) ([@bib3; @bib29]), a state normally achieved in the wild-type upon signal sequence binding. Hence, the *prl* mutants readily adopt an active conformation, allowing the transit of substrates with defective signal sequences. These mutations in SecY (*prlA*) map mostly to the plug (helix 2a), TMS 7, and TMS 10 ([@bib21; @bib29]; Figure 6 in [@bib31]) in the right position to promote the conformational changes observed here. Therefore, we suggest that the structure represents an activated form of the complex favored by the *prl* mutants. For example, the potent suppressor *prlA4* (SecY~F286Y;I408N~) may achieve this by promoting the displacement of TMS 7 (by SecY~F286Y~) and stabilizing an interaction between TMS 7 and 10 (by SecY~I408N~), predisposing it to the conformation observed here in complex with the signal peptide ([Figure 4](#fig4){ref-type="fig"}B). This particular suppressor also promotes the displacement of the plug helix toward TMS 3 of SecE ([@bib30]), as described here. This displacement is also consistent with a known interaction between the *prlA3* site (SecY~F67C~ in helix 2a) and SecE~S120C~ (TMS 3, red sphere in [Figure 4](#fig4){ref-type="fig"}A) in the active complex ([@bib19; @bib30]). This relocation also closely matches a prediction of the plug position in the open state ([@bib26]).

The SecYEG-ribosome complex in the act of cotranslational transport of a membrane protein has also been visualized in a lipid bilayer, in this case encapsulated by nanodiscs ([@bib15]). The structure determined by electron cryomicroscopy of single particles does not report the movements we observe, but does show the nascent signal anchor in a very similar position to the signal sequence ([Figure S2](#figs2){ref-type="fig"}).

The experiments described here profit from the ability of signal sequence peptides to transactivate the SecYEG complex ([Figures 1](#fig1){ref-type="fig"}C--1E; [@bib18]). The preprotein mimics are too short to fully engage the translocon, instead they act to unlock or prime the complex. Therefore, the results reveal part of the preprotein binding site and the architecture of the activated complex in the early stages of the cycle prior to translocation. The signal sequence binding site on the outside of the complex is compatible with a mechanism for translocation described in [Figure 4](#fig4){ref-type="fig"}C and explains why the activation mechanism is allosteric.

The conformational changes in the substrate-bound state, particularly involving TMS 7 of SecY, were not apparent in the complex activated by SecA ([@bib32]) or any other structure. Therefore, they must be specific to the preprotein. These conformational changes would undoubtedly affect the lining of the protein channel, including the hydrophobic seal in the center of SecY ([@bib23; @bib31]), and thereby, together with the displacement of the plug, facilitate channel opening and intercalation of the translocating polypeptide ([Figure 4](#fig4){ref-type="fig"}C). This putative activation step may promote the dislocation of the two halves of SecY about the hinge region between TMS 5 and 6, to allow the passage of proteins through or into membrane ([@bib31]), possibly in the manner described by the structure of the slightly more open state ([@bib11]). The next challenge is to determine the structure of the fully open complex engaged in secretion or with a membrane protein trapped during the insertion process.

Experimental Procedures {#sec4}
=======================

Chromatography media was from GE Healthcare. Detergents were obtained from Glycon and lipids from Avanti. SilverQuest silver staining kit and NuPAGE gels were purchased from Invitrogen. Bio-Beads SM2 were from Bio-Rad. All other materials were supplied by Sigma Aldrich.

Peptide and Protein Production {#sec4.1}
------------------------------

The LamB signal sequence MMITLRKLPLAVAVAAGVMSAQAYA (SS), LamB signal sequence plus the first β strand MMITLRKLPLAVAVAAGVMSAQAYA-VDFHGYARSGIGWTG (SS-β~1~) and the mutant version ([@bib12]) MMITLRKLP-(ΔLAVA)-VAAGVMSAQAYA-VDFHGYARSGIGWTG (SS~Δ4~-β~1~) were synthesized by Dr Graham Bloomberg (University of Bristol).

Protein samples were purified according to published protocols ([@bib27]).

### ATPase and Translocation Assays {#sec4.1.1}

In vitro ATPase and translocation assays involving proOmpA and OmpA were performed essentially as described previously ([@bib27]); see [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"} as well for further details.

### Coreconstitution of SecYEG with Preprotein Peptides {#sec4.1.2}

Proteoliposomes containing SecYEG were reconstituted in the absence or presence of SS, SS-β~1~, or SS~Δ4~-β~1~. The reconstitution mixture contained 1.65 μM SecYEG, 3.2 mg/ml (∼4.6 mM) *E. coli* polar lipids, ±10 μM peptide; for further details see ([@bib27]) and [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"}. Following detergent removal by dialysis and Bio-Bead adsorption, the proteoliposomes were separated from excess unbound peptide by centrifugation and resuspended to give a final SecYEG concentration of 4.6 μM (8.9 mg/ml lipid). The protein composition was then evaluated by SDS-PAGE. High concentrations of lipid disturbed the migration of the peptides at the lower regions of the gel, therefore, reduced quantities (18 pmol ∼1.4 μg SecYEG and 35 μg lipid) were loaded and the peptide content was evaluated by silver staining. The vesicles were then challenged in assays monitoring the translocation of proOmpA and OmpA (as above).

Growth and Analysis of 2D Crystals Containing SecYEG and SS-β~1~ {#sec4.2}
----------------------------------------------------------------

Two-dimensional crystals were grown of SecYEG (3.4 μM) as before ([@bib5]), in the absence or presence of 10 μM SS-β~1~ in the sample and 5 μM in the outside dialysis buffer (sufficient to saturate the sites on SecYEG as the concentrations employed stipulate tight-binding conditions). The crystals (10 μg with respect to the protein, and ∼2 μg lipid) were then subjected to SDS-PAGE before and after exposure to trypsin (0.1 μg for 20 min at room temperature).

### Electron Microscopy, Image Processing, and Model Building {#sec4.2.1}

Electron cryomicroscopy, structure determination and model fitting was carried out in the manner already described for SecYEG alone ([@bib5]); see [Extended Experimental Procedures](#dtbox1){ref-type="boxed-text"} as well for further details. Files describing the models fitted to the experimental map density of the structure are available upon request.

### Determination of Correlation Coefficients {#sec4.2.2}

The map density covering one monomer in each map was masked out and overlapped to the other according to the noncrystallographic 2-fold symmetry ([@bib5]) by MAPROT. The correlation coefficients were then calculated by OVERLAPMAP.

Extended Experimental ProceduresATPase and Translocation AssaysIn vitro ATPase and translocation assays using proOmpA and OmpA were performed at 25°C in 50 mM triethanolamine, 50 mM KCl and 2 mM MgCl~2~ at pH 7.5. Pyruvate kinase (7 U/ml), lactate dehydrogenase (10 U/ml), phosphoenol pyruvate (2 mM) and NADH (0.2 mM) were mixed with SecA (50 nM) and SecYEG (1 μM) reconstituted into proteoliposomes. The reaction was initiated with 1 mM ATP, followed by addition of the peptides in 6 M urea, which had no effect on the ATPase rate in the absence of preprotein. Subsequent addition of proOmpA or OmpA (0.7 μM) initiated translocation-associated ATPase activity, which was measured by the change in absorbance at 340 nm using a Lambda 25 Spectrophotometer (Perkin Elmer). The inclusion of urea at the concentrations used had no effect on the ATPase rates or translocation efficiency.Translocation efficiency was assayed by taking samples from the ATPase reactions and subjecting them to proteinase K digestion (0.2 mg/ml for 45 min on ice). After precipitation by trichloroacetic acid (20%, plus 1 mg/ml BSA, for 30 min on ice), protease-protected substrate was detected by western blot using an antibody raised against proOmpA.Electron Microscopy and Image ProcessingSpecimens for electron cryomicroscopy were prepared by the back-injection method in 4% trehalose ([@bib5]). Images were recorded at liquid-helium temperature in a JEOL 3000 SSF electron microscope at specimen tilts of 0°, 10°, 20°, 30° and 45° at 300 kV and at a magnification of 53,000X in spot-scan mode. Crystal quality was evaluated by optical diffraction and well-ordered areas of 4,000 × 4,000 pixels were digitized on a ZEISS SCAI scanner at 7 μm step size. The lattices were processed by 2dx_image (Gipson et al., 2007) and the image data were merged in plane group *p*12~1b~ with the ORIGTILTK program in the MRC package (Crowther et al., 1996; Henderson et al., 1986). Image amplitudes were scaled with an average temperature factor of −600 Å to compensate for the resolution-dependent degradation of image amplitudes as described previously ([@bib5]). The 3D map was calculated with the CCP4 program suite (1994).Model BuildingThe *E. coli* molecular model of SecYEG ([@bib4; @bib9]) was modified to include the missing helices of SecE and SecG. This combined model was then used as a template for the version of SecYEG ([@bib5]) and for SecYEG-SS-β~1~, fitted to the electron density using COOT (Emsley and Cowtan, 2004). The models were prepared in cartoon representation using PyMOL (The PyMOL Molecular Graphics System, Version 1.3.x, Schrödinger, LLC). The maps were contoured at 1.5 SD.

Supplemental Information {#app3}
========================

Table S1. Electron Crystallographic DataMovie S1. Unlocking the Sec ComplexThe movie depicts the dynamic activation of the SecY complex (cyan; viewed in ribbon representation, from the side with the cytosolic face uppermost). The association of the signal sequence (appears in blue) at the lateral gate coincides with a conformational change in trans-membrane segments 2b (TM2b), 7 (TM7) and the plug (TM2a) of SecY (red to green).Document S1. Article plus Supplemental Information
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![A 40 aa Peptide of LamB SS-β~1~ Competes for Full-Length Preprotein and Activates the SecY Complex\
(A) Addition of LamB SS-β~1~, but not SS~Δ4~-β~1~, inhibits translocation-associated ATPase activity of SecA. ATPase rates were measured using the pyruvate kinase/lactate dehydrogenase linked assay in the presence of 50 nM SecA, 1 mM ATP, 1 μM SecYEG proteoliposomes, and 0.7 μM proOmpA after preincubation with increasing concentrations of the signal sequence peptides.\
(B) Samples used in the ATPase assays shown in (A) were tested for translocation efficiency according to protease protection of proOmpA. Successfully translocated, protease-protected proOmpA was visualized by western blot. The top right-hand lane was loaded as a measure of 10% of the total proOmpA present in the samples.\
(C) Translocation assays (as in B) using OmpA instead of proOmpA. The upper two panels show representative western blots for successfully translocated substrate in the presence of wild-type and mutant peptides; each lane corresponds to the bars in the quantification below, for increasing concentrations (0--100 μM) of peptides: SS-β~1~ (black bars) or SS~Δ4~-β~1~ (gray bars); n = 4--6. The translocation efficiency was calibrated against a 10% standard. Negative (no ATP with 100 μM peptide) and positive (proOmpA without peptide) controls are shown on the right. All error bars denote SD.\
(D) SecYEG vesicles reconstituted in the presence of SS, SS-β~1~, or SS~Δ4~-β~1~ were loaded onto an SDS-PAGE gel and the polypeptides visualized by silver staining.\
(E) Translocation assays for OmpA (as in B) using vesicles incorporating SecYEG with or without peptide. The upper panel shows a representative western, quantified (as in C) in the lower panel (n = 8). The peptide present in the initial reconstitution is indicated below. proOmpA was used as a positive control testing the competence of vesicles reconstituted without preprotein peptides (far left). All error bars denote SD.\
(F) Coomassie-stained SDS-PAGE gel of 2D crystals of SecYEG grown in the presence or absence of SS-β~1~, before and after exposure to 1:100 (w/w) trypsin for 20 min at room temperature. ^∗^Well-known breakdown product of SecY ([@bib8; @bib25]).](gr1){#fig1}

![Structure of SecYEG Bound to the Preprotein Peptide SS-β~1~\
The TMS are labeled for SecY (1-10), SecE (E1-3), SecG (G1 and G2), and the signal sequence (SS). Maps are contoured at 1.5 SD.\
(A and B) Top views from the cytoplasmic side of one crystalline membrane of SecYEG showing map density and super-imposed *E. coli* models ([Experimental Procedures](#sec4){ref-type="sec"}). The lateral gate of the substrate-occupied complex and its equivalent in the complex visualized without peptide are circled in red. (A) Structure of the SecYEG dimer bound to the preprotein mimic. The occupied complex with bound preprotein peptide is on the right-hand side of the dimer, with SecY, E, and G shown, respectively, in purple, salmon, and dark pink. The unoccupied complex is on the left-hand side of the dimer shown with SecY, E, and G in yellow, sand, and orange. (B) SecYEG, without bound preprotein peptide and without the applied 2-fold symmetry ([@bib5]), is shown for comparison with SecY, E, and G in blue, light teal, and gray.\
(C--E) Detailed side views of map density of the SecYEG complex bound to the preprotein mimic (as in (A), right hand complex), with corresponding fitted *E. coli* homology model (purple lines). (C) view from the center of one SecYEG complex out through the lateral gate. (D) Side view toward TMS 2b and 3. ^∗^Denotes the density from the second crystal layer, which is not part of the structure being viewed. (E) looking into the lateral gate from the outside.](gr2){#fig2}

![Comparison of the Lateral Gates of SecYEG Complexes Determined with and without the Preprotein Peptide\
(A--D) Side view detail from outside the lateral gate, as indicated in the respective scheme of the SecYEG dimer (side view, cytoplasm uppermost). The experimental map density is shown (contoured at 1.5 SD) along with the docked TMS (ribbon representation) of the *E. coli* atomic homology model ([Experimental Procedures](#sec4){ref-type="sec"}), colored as in [Figure 2](#fig2){ref-type="fig"}. Selected helices of SecY are labeled by their corresponding number (red numbers denote key TMS). The SecYEG dimer associated with SS-β~1~, with the substrate-occupied (A) and unoccupied (B) monomer complexes; the fitted core α helix of the signal sequence peptide ([@bib16]) is shown in magenta in (A). (C and D) The SecYEG complex determined without peptide, prior to symmetry imposition of the noncrystallographic dimer ([@bib5]).](gr3){#fig3}

![Mechanism of Preprotein-Induced Activation of the SecY Complex\
(A) Cytosolic view of the fitted models of SecYEG determined previously ([@bib4]) overlaid with the one bound by the preprotein peptide; color coding as in [Figure 2](#fig2){ref-type="fig"}, except that the SecYEG formerly determined without peptide is shown in white with the plug (2a) in red. The 4 residues -LAVA- of the signal sequence, which when deleted ablate preprotein transport and peptide activity ([Figures 1](#fig1){ref-type="fig"}A--1E), are shown in cyan. The sites associated with the signal sequence suppressor allele *prlA4* (SecY-F286Y in TMS 7 and SecY-I408N in TMS 10) are shown in SecY determined without added peptide (lime green sticks on white ribbon) and in SecY bound to the preprotein mimic (dark green sticks on purple ribbon). SecE-S120 at the C-terminal periplasmic region of TMS 3, known to interact with the plug (2a; SecY-F67) ([@bib14; @bib30]), is represented by red spheres.\
(B) Detail of the protein channel and lateral gate (as in A). The arrows describe the movement of TMS 2b, 7, and the plug (2a) associated with the binding of signal sequence (magenta, SS).\
(C) Model for activation, channel opening and translocation. Preprotein (blue) with an N-terminal signal sequence (cylinder) is engaged by SecA (red inactive dimer) and targeted to the translocation machinery SecYEG (symmetrical light blue dimer). (I). The initiation of translocation involves ATP hydrolysis and the dissociation of SecA dimers (orange and white monomers) ([@bib10; @bib20; @bib25]), which exposes the signal sequence (II) to facilitate binding at the protein-lipid interface of SecYEG. (III). The association activates one monomer in the SecYEG dimer, breaking the 2-fold symmetry. The activated complex (as in A and B) is primed for translocation (purple), while the passive complex (yellow) becomes tightly closed and assists in the binding of SecA, now fully active (green) ([@bib9]). (IV). ATP hydrolysis results in the intercalation of preprotein, channel opening (green) and translocation. (V). The activated asymmetric conformation can also be promoted by a *trans*-acting signal sequence peptide (dashed box) ([Figures 1](#fig1){ref-type="fig"}C--1E) and is visualized by the structure described here. (VI). In this bound state it is capable of transporting signal sequence-less substrates. (VII and VIII). The *prlA* mutants are predisposed to the activated form of SecYEG (purple) and capable of translocating proteins with defective signal sequences (red band on blue cylinder).](gr4){#fig4}

![Comparison of Double Membrane Crystals of SecYEG with and without Preprotein\
Side view of the SecYEG map with (A) and without (B) bound preprotein (determined previously ([@bib5]), without the imposed non-crystallographic symmetry) and with one dimer fitted into the maps (color coding is as [Figure 2](#fig2){ref-type="fig"}). Both maps are at 8 Å in-plane resolution and contoured at 1.5 SD. The double-membrane crystals of SecYEG prepared in this study (A) are around 12 Å less thick compared to those determined previously (B), and the unit cell is slightly larger. This effect is independent of the presence of the peptide and is due to variation in the crystal packing.](figs1){#figs1}

![Comparison of SecYEG Structure Bound to the Presecretory Signal Sequence and to a Nascent Signal Anchor\
(A) Cytosolic view of the fitted model of the SecYEG dimer bound by preprotein (colored as in [Figure 2](#fig2){ref-type="fig"}) aligned and overlaid with the SecYEG monomer bound by the ribosome nascent chain (RNC) complex ([@bib15]). For the SecYEG-RNC complex the ribosome has been omitted for the purposes of clarity and the complex is colored as follows: SecY, SecE, and SecG (white), nascent signal anchor (SA, green) and plug (2a, red).\
(B) Detail showing the lateral gate (same color coding). Key TMS are labeled in black (SecYEG bound to SSβ~1~) or gray (SecYEG bound to RNC).](figs2){#figs2}
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